Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

MicroRNA-17~92 plays a causative role in lymphomagenesis by coordinating multiple oncogenic pathways.

Jin HY, Oda H, Lai M, Skalsky RL, Bethel K, Shepherd J, Kang SG, Liu WH, Sabouri-Ghomi M, Cullen BR, Rajewsky K, Xiao C.

EMBO J. 2013 Aug 28;32(17):2377-91. doi: 10.1038/emboj.2013.178. Epub 2013 Aug 6.

2.

NF-kappaB/STAT3/PI3K signaling crosstalk in iMyc E mu B lymphoma.

Han SS, Yun H, Son DJ, Tompkins VS, Peng L, Chung ST, Kim JS, Park ES, Janz S.

Mol Cancer. 2010 Apr 30;9:97. doi: 10.1186/1476-4598-9-97.

3.

Myc suppression of Nfkb2 accelerates lymphomagenesis.

Keller U, Huber J, Nilsson JA, Fallahi M, Hall MA, Peschel C, Cleveland JL.

BMC Cancer. 2010 Jul 2;10:348. doi: 10.1186/1471-2407-10-348.

4.

MicroRNA-146a modulates B-cell oncogenesis by regulating Egr1.

Contreras JR, Palanichamy JK, Tran TM, Fernando TR, Rodriguez-Malave NI, Goswami N, Arboleda VA, Casero D, Rao DS.

Oncotarget. 2015 May 10;6(13):11023-37.

5.

MicroRNA 28 controls cell proliferation and is down-regulated in B-cell lymphomas.

Schneider C, Setty M, Holmes AB, Maute RL, Leslie CS, Mussolin L, Rosolen A, Dalla-Favera R, Basso K.

Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):8185-90. doi: 10.1073/pnas.1322466111. Epub 2014 May 19.

6.

MicroRNA-124 links p53 to the NF-κB pathway in B-cell lymphomas.

Jeong D, Kim J, Nam J, Sun H, Lee YH, Lee TJ, Aguiar RC, Kim SW.

Leukemia. 2015 Sep;29(9):1868-74. doi: 10.1038/leu.2015.101. Epub 2015 Apr 27.

PMID:
25915824
7.

Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes.

Xiao C, Srinivasan L, Calado DP, Patterson HC, Zhang B, Wang J, Henderson JM, Kutok JL, Rajewsky K.

Nat Immunol. 2008 Apr;9(4):405-14. doi: 10.1038/ni1575. Epub 2008 Mar 9.

8.

miR-19 is a key oncogenic component of mir-17-92.

Olive V, Bennett MJ, Walker JC, Ma C, Jiang I, Cordon-Cardo C, Li QJ, Lowe SW, Hannon GJ, He L.

Genes Dev. 2009 Dec 15;23(24):2839-49. doi: 10.1101/gad.1861409.

9.

Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis.

Sander S, Calado DP, Srinivasan L, Köchert K, Zhang B, Rosolowski M, Rodig SJ, Holzmann K, Stilgenbauer S, Siebert R, Bullinger L, Rajewsky K.

Cancer Cell. 2012 Aug 14;22(2):167-79. doi: 10.1016/j.ccr.2012.06.012.

10.

MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.

Sampson VB, Rong NH, Han J, Yang Q, Aris V, Soteropoulos P, Petrelli NJ, Dunn SP, Krueger LJ.

Cancer Res. 2007 Oct 15;67(20):9762-70.

11.

miR-155 regulates HGAL expression and increases lymphoma cell motility.

Dagan LN, Jiang X, Bhatt S, Cubedo E, Rajewsky K, Lossos IS.

Blood. 2012 Jan 12;119(2):513-20. doi: 10.1182/blood-2011-08-370536. Epub 2011 Nov 16.

12.

MicroRNA-221 induces cell survival and cisplatin resistance through PI3K/Akt pathway in human osteosarcoma.

Zhao G, Cai C, Yang T, Qiu X, Liao B, Li W, Ji Z, Zhao J, Zhao H, Guo M, Ma Q, Xiao C, Fan Q, Ma B.

PLoS One. 2013;8(1):e53906. doi: 10.1371/journal.pone.0053906. Epub 2013 Jan 23. Erratum in: PLoS One. 2013;8(5). doi:10.1371/annotation/f47e2af6-da90-40ee-871c-f9ed6f58a48c.

13.

A Kaposi's sarcoma-associated herpesvirus-encoded ortholog of microRNA miR-155 induces human splenic B-cell expansion in NOD/LtSz-scid IL2Rγnull mice.

Boss IW, Nadeau PE, Abbott JR, Yang Y, Mergia A, Renne R.

J Virol. 2011 Oct;85(19):9877-86. doi: 10.1128/JVI.05558-11. Epub 2011 Aug 3.

14.

Histone deacetylase inhibitor prevents cell growth in Burkitt's lymphoma by regulating PI3K/Akt pathways and leads to upregulation of miR-143, miR-145, and miR-101.

Ferreira AC, Robaina MC, Rezende LM, Severino P, Klumb CE.

Ann Hematol. 2014 Jun;93(6):983-93. doi: 10.1007/s00277-014-2021-4. Epub 2014 Feb 28.

PMID:
24577510
15.

B-cell malignancies in microRNA Eμ-miR-17~92 transgenic mice.

Sandhu SK, Fassan M, Volinia S, Lovat F, Balatti V, Pekarsky Y, Croce CM.

Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):18208-13. doi: 10.1073/pnas.1315365110. Epub 2013 Oct 21.

16.

Role of microRNA in the pathogenesis of malignant lymphoma.

Tagawa H, Ikeda S, Sawada K.

Cancer Sci. 2013 Jul;104(7):801-9. doi: 10.1111/cas.12160. Epub 2013 Apr 29. Review.

17.

MicroRNAs and lymphomagenesis: a functional review.

Lawrie CH.

Br J Haematol. 2013 Mar;160(5):571-81. doi: 10.1111/bjh.12157. Epub 2012 Dec 4. Review.

PMID:
23205669
18.

Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas.

Mu P, Han YC, Betel D, Yao E, Squatrito M, Ogrodowski P, de Stanchina E, D'Andrea A, Sander C, Ventura A.

Genes Dev. 2009 Dec 15;23(24):2806-11. doi: 10.1101/gad.1872909.

19.

Heat shock protein 90B1 plays an oncogenic role and is a target of microRNA-223 in human osteosarcoma.

Li G, Cai M, Fu D, Chen K, Sun M, Cai Z, Cheng B.

Cell Physiol Biochem. 2012;30(6):1481-90. doi: 10.1159/000343336. Epub 2012 Dec 7.

PMID:
23208072
20.

Selection against PUMA gene expression in Myc-driven B-cell lymphomagenesis.

Garrison SP, Jeffers JR, Yang C, Nilsson JA, Hall MA, Rehg JE, Yue W, Yu J, Zhang L, Onciu M, Sample JT, Cleveland JL, Zambetti GP.

Mol Cell Biol. 2008 Sep;28(17):5391-402. doi: 10.1128/MCB.00907-07. Epub 2008 Jun 23.

Items per page

Supplemental Content

Write to the Help Desk